Literature DB >> 6330509

Epidemiology of malignant mesothelioma in Western Australia.

B K Armstrong, A W Musk, J E Baker, J M Hunt, C C Newall, H R Henzell, B S Blunsdon, M D Clarke-Hundley, S D Woodward, M S Hobbs.   

Abstract

Crocidolite was mined and milled at Wittenoom Gorge in Western Australia from 1943 to 1966. Between 1960-1964 and 1980-1982, the estimated incidence of malignant mesothelioma in Western Australia rose from 0.6/100 000 in men and less than 0.1/100 000 in women, aged 35 years or older, to 6.6/100 000 in men and 0.7/100 000 in women in this age group. Overall, 97 (70%) of 138 patients with malignant mesothelioma had definite or probable exposure to asbestos; 76 of these (55%) to Western Australian crocidolite. Of the latter 76 patients, 56 had worked in the mine or mill at Wittenoom and 4 had non-occupational exposure in the Wittenoom area; the remaining 16 had been exposed to crocidolite elsewhere in the State. There were only 4 (3%) patients with malignant peritoneal mesothelioma, of whom three had been exposed to crocidolite.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6330509

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  9 in total

1.  Malignant mesothelioma in a cohort of asbestos insulation workers: clinical presentation, diagnosis, and causes of death.

Authors:  J Ribak; R Lilis; Y Suzuki; L Penner; I J Selikoff
Journal:  Br J Ind Med       Date:  1988-03

2.  Trends and geographical patterns of pleural mesotheliomas in the Netherlands 1970-87.

Authors:  J M Meijers; H T Planteydt; J J Slangen; G M Swaen; C van Vliet; F Sturmans
Journal:  Br J Ind Med       Date:  1990-11

3.  Chemosensitivity and cytokine sensitivity of malignant mesothelioma.

Authors:  R V Bowman; L S Manning; M R Davis; B W Robinson
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 4.  The health impact of nonoccupational exposure to asbestos: what do we know?

Authors:  Marcel Goldberg; Danièle Luce
Journal:  Eur J Cancer Prev       Date:  2009-11       Impact factor: 2.497

5.  Malignant mesothelioma: attributable risk of asbestos exposure.

Authors:  R Spirtas; E F Heineman; L Bernstein; G W Beebe; R J Keehn; A Stark; B L Harlow; J Benichou
Journal:  Occup Environ Med       Date:  1994-12       Impact factor: 4.402

6.  Differences in occupational mortality from pleural cancer, peritoneal cancer, and asbestosis.

Authors:  D Coggon; H Inskip; P Winter; B Pannett
Journal:  Occup Environ Med       Date:  1995-11       Impact factor: 4.402

7.  LRRN4 and UPK3B are markers of primary mesothelial cells.

Authors:  Mutsumi Kanamori-Katayama; Ai Kaiho; Yuri Ishizu; Yuko Okamura-Oho; Okio Hino; Masaaki Abe; Takumi Kishimoto; Hisahiko Sekihara; Yukio Nakamura; Harukazu Suzuki; Alistair R R Forrest; Yoshihide Hayashizaki
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

Review 8.  Applying definitions of "asbestos" to environmental and "low-dose" exposure levels and health effects, particularly malignant mesothelioma.

Authors:  B W Case; J L Abraham; G Meeker; F D Pooley; K E Pinkerton
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

Review 9.  Nonpulmonary outcomes of asbestos exposure.

Authors:  Melisa Bunderson-Schelvan; Jean C Pfau; Robert Crouch; Andrij Holian
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.